-+ 0.00%
-+ 0.00%
-+ 0.00%

Mereo BioPharma Group Q3 EPS $(0.01), Inline, Sales $800.000K

Benzinga·11/09/2026 13:40:25
Listen to the news
Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported $800.000 thousand in sales this quarter.